IMP
Process View
amine metabolic process
The chemical reactions and pathways involving any organic compound that is weakly basic in character and contains an amino or a substituted amino group, as carried out by individual cells. Amines are called primary, secondary, or tertiary according to whether one, two, or three carbon atoms are attached to the nitrogen atom.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "amine metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGFR | epidermal growth factor receptor | 1.000 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 1.000 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 1.000 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 1.000 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 1.000 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 1.000 | ||
| SYK | spleen tyrosine kinase | 0.999 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.999 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.999 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.999 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.999 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.998 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.998 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.998 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.996 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.996 | ||
| GHR | growth hormone receptor | 0.995 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.995 | ||
| SMAD3 | SMAD family member 3 | 0.995 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.993 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.990 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.990 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.990 | ||
| FHL2 | four and a half LIM domains 2 | 0.989 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.989 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.989 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.988 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.986 | ||
| PRKCA | protein kinase C, alpha | 0.985 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.985 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.984 | ||
| ESR1 | estrogen receptor 1 | 0.982 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.982 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.981 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.981 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.979 | ||
| EPHA2 | EPH receptor A2 | 0.978 | ||
| NCK1 | NCK adaptor protein 1 | 0.973 | ||
| MAPT | microtubule-associated protein tau | 0.973 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.969 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.968 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.963 | ||
| WDR5 | WD repeat domain 5 | 0.963 | ||
| APP | amyloid beta (A4) precursor protein | 0.962 | ||
| SFN | stratifin | 0.960 | ||
| VEGFA | vascular endothelial growth factor A | 0.958 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.953 | ||
| AXL | AXL receptor tyrosine kinase | 0.951 | ||
| INSR | insulin receptor | 0.947 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.944 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.941 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.941 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.939 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.936 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.934 | ||
| SMAD7 | SMAD family member 7 | 0.931 | ||
| CBX5 | chromobox homolog 5 | 0.929 | ||
| FN1 | fibronectin 1 | 0.928 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.926 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.919 | ||
| SIRT1 | sirtuin 1 | 0.919 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.916 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.912 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.909 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.907 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.904 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.904 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.901 | ||
| AR | androgen receptor | 0.901 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.901 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.898 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.893 | ||
| DLG1 | discs, large homolog 1 (Drosophila) | 0.887 | ||
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.885 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.883 | ||
| GH1 | growth hormone 1 | 0.883 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.882 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.881 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.874 | ||
| PAX3 | paired box 3 | 0.872 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.869 | ||
| CREBBP | CREB binding protein | 0.867 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.864 | ||
| HDAC1 | histone deacetylase 1 | 0.862 | ||
| NRP1 | neuropilin 1 | 0.860 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.853 | ||
| SMAD2 | SMAD family member 2 | 0.850 | ||
| ENG | endoglin | 0.849 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.844 | ||
| ABI2 | abl-interactor 2 | 0.844 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.842 | ||
| TLN1 | talin 1 | 0.839 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.838 | ||
| PTEN | phosphatase and tensin homolog | 0.837 | ||
| FLNB | filamin B, beta | 0.832 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.831 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.830 | ||
| CSNK2B | casein kinase 2, beta polypeptide | 0.824 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.817 | ||
| EPOR | erythropoietin receptor | 0.815 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.813 | ||
| A2M | alpha-2-macroglobulin | 0.812 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.810 | ||
| SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.809 | ||
| FLNA | filamin A, alpha | 0.807 | ||
| CD28 | CD28 molecule | 0.799 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.798 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.796 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.796 | ||
| MPDZ | multiple PDZ domain protein | 0.795 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.790 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.788 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.783 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.780 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.775 | ||
| TP53 | tumor protein p53 | 0.773 | ||
| ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | 0.773 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.771 | ||
| RBBP5 | retinoblastoma binding protein 5 | 0.766 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.762 | ||
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.762 | ||
| THBS1 | thrombospondin 1 | 0.758 | ||
| ATF3 | activating transcription factor 3 | 0.756 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.756 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.754 | ||
| PRKCZ | protein kinase C, zeta | 0.753 | Human | |
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.743 | ||
| YAP1 | Yes-associated protein 1 | 0.741 | ||
| DTNA | dystrobrevin, alpha | 0.736 | ||
| AXIN1 | axin 1 | 0.735 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.733 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.732 | ||
| CSH1 | chorionic somatomammotropin hormone 1 (placental lactogen) | 0.730 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.727 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.726 | ||
| EP300 | E1A binding protein p300 | 0.715 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.710 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.708 | ||
| BCL2L1 | BCL2-like 1 | 0.707 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.707 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.706 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.702 | ||
| SMAD1 | SMAD family member 1 | 0.701 | ||
| SLA | Src-like-adaptor | 0.700 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.700 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.700 | ||
| TNF | tumor necrosis factor | 0.700 | ||
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.697 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.696 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.696 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.693 | ||
| MSN | moesin | 0.692 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.690 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.687 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.679 | ||
| MYO10 | myosin X | 0.676 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.671 | ||
| PFN1 | profilin 1 | 0.670 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.668 | ||
| APOA1 | apolipoprotein A-I | 0.665 | ||
| JUN | jun proto-oncogene | 0.665 | ||
| JAG1 | jagged 1 | 0.664 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.664 | ||
| SOCS2 | suppressor of cytokine signaling 2 | 0.660 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.657 | ||
| ACTB | actin, beta | 0.656 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.653 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.653 | ||
| HCK | hemopoietic cell kinase | 0.651 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.651 | ||
| BRCA1 | breast cancer 1, early onset | 0.651 | ||
| RB1 | retinoblastoma 1 | 0.649 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.648 | ||
| IL10 | interleukin 10 | 0.640 | ||
| EED | embryonic ectoderm development | 0.639 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.638 | ||
| CD2AP | CD2-associated protein | 0.637 | ||
| LIFR | leukemia inhibitory factor receptor alpha | 0.637 | ||
| APOE | apolipoprotein E | 0.636 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.635 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.618 | ||
| RPA1 | replication protein A1, 70kDa | 0.618 | ||
| SCN5A | sodium channel, voltage-gated, type V, alpha subunit | 0.617 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.613 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.611 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.608 | ||
| TBX5 | T-box 5 | 0.608 | ||
| FHL1 | four and a half LIM domains 1 | 0.607 | ||
| CSH2 | chorionic somatomammotropin hormone 2 | 0.607 | ||
| JAK3 | Janus kinase 3 | 0.606 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.606 | ||
| MAPK12 | mitogen-activated protein kinase 12 | 0.601 | ||
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.599 | ||
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.594 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.594 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.593 | ||
| ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) | 0.592 | Yeast | |
| RTF1 | Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.591 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.590 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.587 | ||
| BLNK | B-cell linker | 0.584 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.584 | ||
| PROX1 | prospero homeobox 1 | 0.583 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.582 | ||
| BCLAF1 | BCL2-associated transcription factor 1 | 0.582 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.580 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.579 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.570 | ||
| ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | 0.570 | Human | |
| PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.569 | ||
| MEN1 | multiple endocrine neoplasia I | 0.567 | ||
| SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 0.566 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.563 | ||
| KLF6 | Kruppel-like factor 6 | 0.561 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.561 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.556 | ||
| GH2 | growth hormone 2 | 0.555 | ||
| HDAC7 | histone deacetylase 7 | 0.555 | ||
| CHD8 | chromodomain helicase DNA binding protein 8 | 0.552 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.552 | ||
| DCN | decorin | 0.551 | ||
| PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit | 0.549 | ||
| CBX1 | chromobox homolog 1 | 0.548 | ||
| ITGA6 | integrin, alpha 6 | 0.546 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.543 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.540 | ||
| NUP153 | nucleoporin 153kDa | 0.538 | ||
| MEOX1 | mesenchyme homeobox 1 | 0.538 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.538 | ||
| FGA | fibrinogen alpha chain | 0.536 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.527 | ||
| RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | 0.526 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.524 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.521 | ||
| TCEB1 | transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) | 0.517 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.515 | ||
| BCR | breakpoint cluster region | 0.515 | ||
| STK11 | serine/threonine kinase 11 | 0.515 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.513 | ||
| TNS4 | tensin 4 | 0.509 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.509 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.509 | ||
| PLEK | pleckstrin | 0.509 | ||
| RPLP1 | ribosomal protein, large, P1 | 0.509 | ||
| CSNK1G3 | casein kinase 1, gamma 3 | 0.508 | ||
| PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.506 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.506 | ||
| MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0.504 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.502 | ||
| PRKCE | protein kinase C, epsilon | 0.501 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.500 | ||
| APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 | 0.500 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.499 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.497 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.494 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.493 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.492 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.491 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.488 | ||
| ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 | 0.488 | Yeast | |
| FZD1 | frizzled homolog 1 (Drosophila) | 0.487 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.486 | ||
| CTGF | connective tissue growth factor | 0.485 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.484 | ||
| TNC | tenascin C | 0.483 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.482 | ||
| PDZD11 | PDZ domain containing 11 | 0.482 | ||
| SCHIP1 | schwannomin interacting protein 1 | 0.481 | ||
| IK | IK cytokine, down-regulator of HLA II | 0.480 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.479 | ||
| MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.479 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.479 | ||
| CD22 | CD22 molecule | 0.478 | ||
| STAB1 | stabilin 1 | 0.475 | ||
| SH2D1A | SH2 domain containing 1A | 0.474 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.473 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.473 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.472 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.470 | ||
| PRR5 | proline rich 5 (renal) | 0.470 | ||
| NRP2 | neuropilin 2 | 0.470 | ||
| RHOB | ras homolog gene family, member B | 0.470 | ||
| LAT | linker for activation of T cells | 0.469 | ||
| ZNF496 | zinc finger protein 496 | 0.466 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.466 | ||
| CD86 | CD86 molecule | 0.466 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.464 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.463 | ||
| FGF3 | fibroblast growth factor 3 | 0.462 | ||
| PRKCB | protein kinase C, beta | 0.461 | ||
| ANXA1 | annexin A1 | 0.459 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.459 | ||
| NKX2-1 | NK2 homeobox 1 | 0.458 | ||
| BLK | B lymphoid tyrosine kinase | 0.458 | ||
| APLP1 | amyloid beta (A4) precursor-like protein 1 | 0.457 | ||
| DARC | Duffy blood group, chemokine receptor | 0.456 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.455 | ||
| STK10 | serine/threonine kinase 10 | 0.455 | ||
| MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | 0.454 | ||
| STC1 | stanniocalcin 1 | 0.453 | ||
| FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0.453 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.453 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.450 | ||
| KLHL3 | kelch-like 3 (Drosophila) | 0.450 | ||
| PRNP | prion protein | 0.448 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.448 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.447 | ||
| BCL9 | B-cell CLL/lymphoma 9 | 0.447 | ||
| SOCS5 | suppressor of cytokine signaling 5 | 0.447 | ||
| SMAD6 | SMAD family member 6 | 0.445 | ||
| RAN | RAN, member RAS oncogene family | 0.445 | ||
| CD84 | CD84 molecule | 0.444 | ||
| CCKBR | cholecystokinin B receptor | 0.443 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.443 | ||
| MAP1B | microtubule-associated protein 1B | 0.441 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.439 | ||
| CAV2 | caveolin 2 | 0.438 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.437 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.437 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.436 | ||
| NTF3 | neurotrophin 3 | 0.432 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.432 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.431 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.431 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.431 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.430 | ||
| RXRA | retinoid X receptor, alpha | 0.430 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.429 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.428 | ||
| ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 0.428 | ||
| GDF9 | growth differentiation factor 9 | 0.427 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.426 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.426 | ||
| TLK1 | tousled-like kinase 1 | 0.425 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.425 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.425 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.423 | ||
| CALCA | calcitonin-related polypeptide alpha | 0.422 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.420 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.420 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.419 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.418 | ||
| GAS7 | growth arrest-specific 7 | 0.418 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.416 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.415 | ||
| NGFR | nerve growth factor receptor | 0.414 | ||
| ANGPT2 | angiopoietin 2 | 0.409 | ||
| PTPRN | protein tyrosine phosphatase, receptor type, N | 0.409 | ||
| CDCP1 | CUB domain containing protein 1 | 0.408 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.408 | ||
| KPNA2 | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | 0.406 | ||
| HIST1H3B | histone cluster 1, H3b | 0.406 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.405 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.405 | ||
| SPRR2A | small proline-rich protein 2A | 0.404 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.403 | ||
| SSTR2 | somatostatin receptor 2 | 0.403 | ||
| EFNA5 | ephrin-A5 | 0.403 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.402 | ||
| FOSL1 | FOS-like antigen 1 | 0.402 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.401 | ||
| XAB2 | XPA binding protein 2 | 0.399 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.399 | ||
| DLG5 | discs, large homolog 5 (Drosophila) | 0.398 | ||
| BDNF | brain-derived neurotrophic factor | 0.397 | ||
| EPHA3 | EPH receptor A3 | 0.394 | ||
| APH1A | anterior pharynx defective 1 homolog A (C. elegans) | 0.392 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.391 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.391 | ||
| RET | ret proto-oncogene | 0.391 | ||
| MMS22L | MMS22-like, DNA repair protein | 0.390 | ||
| PDGFC | platelet derived growth factor C | 0.386 | ||
| CHD3 | chromodomain helicase DNA binding protein 3 | 0.385 | ||
| MBNL1 | muscleblind-like (Drosophila) | 0.384 | ||
| ANGPT1 | angiopoietin 1 | 0.384 | ||
| SIGMAR1 | sigma non-opioid intracellular receptor 1 | 0.384 | ||
| MAP4K3 | mitogen-activated protein kinase kinase kinase kinase 3 | 0.382 | ||
| VEGFC | vascular endothelial growth factor C | 0.382 | ||
| ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 0.382 | ||
| ZYX | zyxin | 0.382 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.382 | ||
| CDK17 | cyclin-dependent kinase 17 | 0.381 | ||
| OSMR | oncostatin M receptor | 0.380 | ||
| GRM1 | glutamate receptor, metabotropic 1 | 0.379 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.378 | ||
| SELE | selectin E | 0.377 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.377 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.377 | ||
| SFRP5 | secreted frizzled-related protein 5 | 0.376 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.376 | ||
| PGF | placental growth factor | 0.376 | ||
| KSR1 | kinase suppressor of ras 1 | 0.375 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.374 | ||
| SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.374 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.373 | ||
| INHBA | inhibin, beta A | 0.372 | ||
| EPHA7 | EPH receptor A7 | 0.371 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.370 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.369 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.369 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.368 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.368 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.367 | ||
| EFNB2 | ephrin-B2 | 0.367 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.367 | ||
| CD163 | CD163 molecule | 0.366 | ||
| EGF | epidermal growth factor | 0.365 | ||
| CRMP1 | collapsin response mediator protein 1 | 0.365 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.365 | ||
| LRIF1 | ligand dependent nuclear receptor interacting factor 1 | 0.364 | ||
| GCGR | glucagon receptor | 0.364 | ||
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) | 0.364 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.363 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.363 | ||
| HDAC6 | histone deacetylase 6 | 0.363 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.361 | ||
| FGF7 | fibroblast growth factor 7 | 0.360 | Rat | |
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.360 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.359 | ||
| DUSP7 | dual specificity phosphatase 7 | 0.358 | ||
| ANKRD28 | ankyrin repeat domain 28 | 0.356 | ||
| HAS2 | hyaluronan synthase 2 | 0.355 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.355 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.354 | ||
| NCL | nucleolin | 0.353 | ||
| RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.353 | ||
| FBXO11 | F-box protein 11 | 0.353 | ||
| VIM | vimentin | 0.352 | ||
| RPTOR | regulatory associated protein of MTOR, complex 1 | 0.351 | ||
| RNF11 | ring finger protein 11 | 0.351 | ||
| FST | follistatin | 0.350 | ||
| RANBP9 | RAN binding protein 9 | 0.349 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.348 | ||
| MORC3 | MORC family CW-type zinc finger 3 | 0.347 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.346 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.346 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.345 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.344 | ||
| POLR2A | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | 0.344 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.344 | ||
| EZR | ezrin | 0.343 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.343 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.343 | ||
| PKP4 | plakophilin 4 | 0.342 | ||
| SNX9 | sorting nexin 9 | 0.341 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.340 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.339 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.339 | ||
| NOS2 | nitric oxide synthase 2, inducible | 0.339 | ||
| EIF3B | eukaryotic translation initiation factor 3, subunit B | 0.338 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.336 | ||
| ADNP | activity-dependent neuroprotector homeobox | 0.335 | ||
| F2RL1 | coagulation factor II (thrombin) receptor-like 1 | 0.335 | ||
| SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 0.334 | ||
| PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 0.334 | ||
| EFNB3 | ephrin-B3 | 0.334 | ||
| IDE | insulin-degrading enzyme | 0.333 | ||
| PAX7 | paired box 7 | 0.333 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.333 | ||
| SSTR3 | somatostatin receptor 3 | 0.333 | ||
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.332 | ||
| CXXC1 | CXXC finger protein 1 | 0.331 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.330 | ||
| HP | haptoglobin | 0.330 | ||
| KAT5 | K(lysine) acetyltransferase 5 | 0.330 | ||
| CSHL1 | chorionic somatomammotropin hormone-like 1 | 0.328 | ||
| EIF6 | eukaryotic translation initiation factor 6 | 0.328 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.327 | ||
| CCND2 | cyclin D2 | 0.326 | ||
| FAT1 | FAT tumor suppressor homolog 1 (Drosophila) | 0.325 | ||
| FGF6 | fibroblast growth factor 6 | 0.325 | ||
| IL9 | interleukin 9 | 0.323 | ||
| OSM | oncostatin M | 0.323 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.322 | ||
| DDA1 | DET1 and DDB1 associated 1 | 0.322 | ||
| AHNAK | AHNAK nucleoprotein | 0.321 | ||
| NME1 | non-metastatic cells 1, protein (NM23A) expressed in | 0.321 | ||
| PREX1 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 0.320 | ||
| IL2RB | interleukin 2 receptor, beta | 0.318 | ||
| GFAP | glial fibrillary acidic protein | 0.318 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.317 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.316 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.316 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.315 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.315 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.315 | ||
| ADRA1D | adrenergic, alpha-1D-, receptor | 0.314 | ||
| VAC14 | Vac14 homolog (S. cerevisiae) | 0.314 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.313 | ||
| JAM2 | junctional adhesion molecule 2 | 0.313 | ||
| E2F3 | E2F transcription factor 3 | 0.312 | ||
| IER3 | immediate early response 3 | 0.311 | ||
| INO80C | INO80 complex subunit C | 0.311 | ||
| CH25H | cholesterol 25-hydroxylase | 0.310 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.310 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.309 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.309 | ||
| CD93 | CD93 molecule | 0.307 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.305 | ||
| CBX3 | chromobox homolog 3 | 0.304 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.304 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.304 | ||
| CDC73 | cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.303 | ||
| ARRB1 | arrestin, beta 1 | 0.301 | ||
| MLL3 | myeloid/lymphoid or mixed-lineage leukemia 3 | 0.301 | ||
| F2RL3 | coagulation factor II (thrombin) receptor-like 3 | 0.301 | ||
| ZFPM1 | zinc finger protein, multitype 1 | 0.301 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.299 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.299 | ||
| ZNF746 | zinc finger protein 746 | 0.299 | ||
| FOXO1 | forkhead box O1 | 0.299 | ||
| ITGA7 | integrin, alpha 7 | 0.299 | ||
| FZD5 | frizzled homolog 5 (Drosophila) | 0.298 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.298 | ||
| RANBP2 | RAN binding protein 2 | 0.298 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.298 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.297 | ||
| SELPLG | selectin P ligand | 0.297 | ||
| BTG1 | B-cell translocation gene 1, anti-proliferative | 0.297 | ||
| TG | thyroglobulin | 0.297 | ||
| RNF138 | ring finger protein 138 | 0.296 | ||
| ITSN1 | intersectin 1 (SH3 domain protein) | 0.296 | ||
| SOX7 | SRY (sex determining region Y)-box 7 | 0.296 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.296 | ||
| IL22 | interleukin 22 | 0.295 | ||
| IRF8 | interferon regulatory factor 8 | 0.295 | ||
| IL6R | interleukin 6 receptor | 0.294 | ||
| MAP2K2 | mitogen-activated protein kinase kinase 2 | 0.293 | ||
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.293 | ||
| GNA13 | guanine nucleotide binding protein (G protein), alpha 13 | 0.291 | ||
| KITLG | KIT ligand | 0.291 | ||
| MEST | mesoderm specific transcript homolog (mouse) | 0.290 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.290 | ||
| EDN1 | endothelin 1 | 0.289 | ||
| CDAN1 | congenital dyserythropoietic anemia, type I | 0.289 | ||
| CLCN3 | chloride channel 3 | 0.289 | ||
| HMOX2 | heme oxygenase (decycling) 2 | 0.288 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.287 | ||
| EXT1 | exostosin 1 | 0.286 | ||
| MLL2 | myeloid/lymphoid or mixed-lineage leukemia 2 | 0.286 | ||
| BRF2 | BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like | 0.286 | ||
| RND3 | Rho family GTPase 3 | 0.286 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.286 | ||
| HSPA1L | heat shock 70kDa protein 1-like | 0.285 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.285 | ||
| ERBB2IP | erbb2 interacting protein | 0.284 | ||
| DLG2 | discs, large homolog 2 (Drosophila) | 0.284 | ||
| DLC1 | deleted in liver cancer 1 | 0.284 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.283 | ||
| PLXDC1 | plexin domain containing 1 | 0.282 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.282 | ||
| REV3L | REV3-like, catalytic subunit of DNA polymerase zeta (yeast) | 0.281 | ||
| SOX13 | SRY (sex determining region Y)-box 13 | 0.281 | ||
| GPBP1 | GC-rich promoter binding protein 1 | 0.281 | ||
| MCAM | melanoma cell adhesion molecule | 0.280 | ||
| KNG1 | kininogen 1 | 0.280 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.280 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.279 | ||
| IL13 | interleukin 13 | 0.279 | ||
| NOTCH4 | notch 4 | 0.278 | ||
| SMAD5 | SMAD family member 5 | 0.278 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.278 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.278 | ||
| TUBB2A | tubulin, beta 2A | 0.278 | ||
| IL8 | interleukin 8 | 0.277 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.276 | ||
| ARHGAP5 | Rho GTPase activating protein 5 | 0.276 | ||
| C8B | complement component 8, beta polypeptide | 0.276 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.275 | ||
| CMPK1 | cytidine monophosphate (UMP-CMP) kinase 1, cytosolic | 0.275 | ||
| VIPR2 | vasoactive intestinal peptide receptor 2 | 0.274 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.274 | ||
| CD2 | CD2 molecule | 0.274 | ||
| OSBPL8 | oxysterol binding protein-like 8 | 0.273 | ||
| EFNA1 | ephrin-A1 | 0.273 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.273 | ||
| INHBB | inhibin, beta B | 0.272 | ||
| MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | 0.272 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.272 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.271 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.271 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.270 | ||
| AKT1S1 | AKT1 substrate 1 (proline-rich) | 0.270 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.269 | ||
| TCEAL5 | transcription elongation factor A (SII)-like 5 | 0.268 | ||
| ETV1 | ets variant 1 | 0.268 | ||
| PTHLH | parathyroid hormone-like hormone | 0.267 | ||
| APOC2 | apolipoprotein C-II | 0.267 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.266 | ||
| HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.266 | ||
| BAD | BCL2-associated agonist of cell death | 0.266 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.266 | ||
| CD9 | CD9 molecule | 0.265 | ||
| F11R | F11 receptor | 0.265 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.265 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.265 | ||
| PDE10A | phosphodiesterase 10A | 0.264 | ||
| CD274 | CD274 molecule | 0.264 | ||
| TONSL | tonsoku-like, DNA repair protein | 0.263 | ||
| ANGPT4 | angiopoietin 4 | 0.263 | ||
| LRP5 | low density lipoprotein receptor-related protein 5 | 0.263 | ||
| FOXF1 | forkhead box F1 | 0.263 | ||
| TYK2 | tyrosine kinase 2 | 0.263 | ||
| PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 0.263 | ||
| MBIP | MAP3K12 binding inhibitory protein 1 | 0.263 | ||
| RBBP7 | retinoblastoma binding protein 7 | 0.263 | ||
| OPRM1 | opioid receptor, mu 1 | 0.260 | ||
| PLK2 | polo-like kinase 2 | 0.260 | ||
| MBD4 | methyl-CpG binding domain protein 4 | 0.259 | ||
| UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | 0.259 | ||
| PRRX1 | paired related homeobox 1 | 0.258 | ||
| PINK1 | PTEN induced putative kinase 1 | 0.257 | ||
| RHOU | ras homolog gene family, member U | 0.257 | ||
| RUNX2 | runt-related transcription factor 2 | 0.257 | ||
| MLN | motilin | 0.257 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.257 | ||
| NOTCH3 | notch 3 | 0.256 | ||
| GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O | 0.256 | ||
| PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 0.255 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.255 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.254 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.254 | ||
| SOX4 | SRY (sex determining region Y)-box 4 | 0.253 | ||
| CD97 | CD97 molecule | 0.252 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.252 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.250 | ||
| CTBP1 | C-terminal binding protein 1 | 0.250 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.250 | ||
| ESRRG | estrogen-related receptor gamma | 0.249 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.249 | ||
| PBK | PDZ binding kinase | 0.249 | ||
| TGFA | transforming growth factor, alpha | 0.249 | ||
| PRMT1 | protein arginine methyltransferase 1 | 0.248 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.248 | ||
| TRIP13 | thyroid hormone receptor interactor 13 | 0.248 | ||
| FGF4 | fibroblast growth factor 4 | 0.248 | ||
| BAIAP2 | BAI1-associated protein 2 | 0.248 | ||
| APOC1 | apolipoprotein C-I | 0.248 | ||
| HPGDS | hematopoietic prostaglandin D synthase | 0.246 | ||
| EIF4E | eukaryotic translation initiation factor 4E | 0.246 | ||
| FGF18 | fibroblast growth factor 18 | 0.246 | ||
| CALCR | calcitonin receptor | 0.246 | ||
| ATG3 | ATG3 autophagy related 3 homolog (S. cerevisiae) | 0.246 | ||
| RAB6A | RAB6A, member RAS oncogene family | 0.245 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.245 | ||
| JAK1 | Janus kinase 1 | 0.245 | ||
| GATA4 | GATA binding protein 4 | 0.244 | Human | |
| CCR9 | chemokine (C-C motif) receptor 9 | 0.244 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.244 | ||
| NTSR2 | neurotensin receptor 2 | 0.244 | ||
| IL1A | interleukin 1, alpha | 0.244 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.243 | ||
| YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.242 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.242 | ||
| ROS1 | c-ros oncogene 1 , receptor tyrosine kinase | 0.242 | ||
| HIC1 | hypermethylated in cancer 1 | 0.242 | ||
| IRS1 | insulin receptor substrate 1 | 0.241 | ||
| KCNC3 | potassium voltage-gated channel, Shaw-related subfamily, member 3 | 0.241 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.241 | ||
| ADRB3 | adrenergic, beta-3-, receptor | 0.241 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.241 | ||
| ITGA1 | integrin, alpha 1 | 0.240 | ||
| EMP1 | epithelial membrane protein 1 | 0.240 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.240 | ||
| AMOTL2 | angiomotin like 2 | 0.240 | ||
| JUP | junction plakoglobin | 0.239 | ||
| JUNB | jun B proto-oncogene | 0.239 | ||
| IL4R | interleukin 4 receptor | 0.239 | ||
| EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 0.239 | ||
| IPO7 | importin 7 | 0.238 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.236 | ||
| NOS1 | nitric oxide synthase 1 (neuronal) | 0.236 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.235 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.235 | ||
| APOC3 | apolipoprotein C-III | 0.235 | ||
| KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 0.234 | ||
| KLF13 | Kruppel-like factor 13 | 0.234 | ||
| FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0.234 | ||
| EIF3A | eukaryotic translation initiation factor 3, subunit A | 0.234 | ||
| PYY | peptide YY | 0.233 | ||
| MED28 | mediator complex subunit 28 | 0.233 | ||
| ITGB8 | integrin, beta 8 | 0.233 | ||
| EPHB2 | EPH receptor B2 | 0.233 | ||
| ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | 0.232 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.232 | ||
| MARCKSL1 | MARCKS-like 1 | 0.232 | ||
| PVR | poliovirus receptor | 0.232 | ||
| IL11 | interleukin 11 | 0.232 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.232 | ||
| PPHLN1 | periphilin 1 | 0.232 | ||
| VDAC1 | voltage-dependent anion channel 1 | 0.231 | ||
| NACAD | NAC alpha domain containing | 0.231 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.231 | ||
| FGF10 | fibroblast growth factor 10 | 0.231 | ||
| RARB | retinoic acid receptor, beta | 0.231 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.230 | ||
| STC2 | stanniocalcin 2 | 0.230 | ||
| ATXN7 | ataxin 7 | 0.230 | ||
| DOK4 | docking protein 4 | 0.230 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.229 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.229 | ||
| TBCD | tubulin folding cofactor D | 0.229 | ||
| ADAM10 | ADAM metallopeptidase domain 10 | 0.228 | ||
| SAT2 | spermidine/spermine N1-acetyltransferase family member 2 | 0.227 | ||
| SMN1 | survival of motor neuron 1, telomeric | 0.227 | ||
| KDM6B | lysine (K)-specific demethylase 6B | 0.227 | ||
| SFTPB | surfactant protein B | 0.227 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.227 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.226 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.226 | ||
| IRF4 | interferon regulatory factor 4 | 0.226 | ||
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | 0.225 | ||
| CCDC88A | coiled-coil domain containing 88A | 0.225 | ||
| SIPA1 | signal-induced proliferation-associated 1 | 0.224 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.224 | ||
| ATG12 | ATG12 autophagy related 12 homolog (S. cerevisiae) | 0.223 | ||
| EDN3 | endothelin 3 | 0.223 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.223 | ||
| PDZK1 | PDZ domain containing 1 | 0.223 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.222 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.222 | ||
| HTR4 | 5-hydroxytryptamine (serotonin) receptor 4 | 0.222 | ||
| C5orf41 | chromosome 5 open reading frame 41 | 0.221 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.221 | ||
| MT1A | metallothionein 1A | 0.221 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.221 | ||
| FOSL2 | FOS-like antigen 2 | 0.221 | ||
| SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.220 | ||
| RHO | rhodopsin | 0.220 | ||
| TBX2 | T-box 2 | 0.220 | ||
| RUVBL1 | RuvB-like 1 (E. coli) | 0.220 | ||
| CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.220 | ||
| MICAL1 | microtubule associated monoxygenase, calponin and LIM domain containing 1 | 0.220 | ||
| GPC3 | glypican 3 | 0.220 | ||
| OXSR1 | oxidative-stress responsive 1 | 0.220 | ||
| SMS | spermine synthase | 0.220 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.220 | ||
| KIF2A | kinesin heavy chain member 2A | 0.219 | ||
| IER2 | immediate early response 2 | 0.219 | ||
| BAZ2B | bromodomain adjacent to zinc finger domain, 2B | 0.219 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.219 | ||
| CDX2 | caudal type homeobox 2 | 0.219 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.219 | ||
| SH3D19 | SH3 domain containing 19 | 0.218 | ||
| GSPT1 | G1 to S phase transition 1 | 0.218 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.218 | ||
| SLC38A2 | solute carrier family 38, member 2 | 0.218 | ||
| IL17RA | interleukin 17 receptor A | 0.218 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.217 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.217 |